(Q70503831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

M E Ellis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

O Alfurayh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

M A Halim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

J O Sieck

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

M A Ali

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

S S Bernvil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

H Ali

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

Y Barri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

A Ayub

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

M al-Fadda

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 June 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

210-216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

11 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Etiology of Liver Disease in Renal-Transplant Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

Observations on Decreased Serum Glutamic Oxalacetic Transaminase (SGOT) Activity in Azotemic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980248-X

7 January 2021

10.1016/S0168-8278(05)80248-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8409337%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference